Chemoinformaics analysis of Igwhgimymcusqi-uhfffaoysa-
| Molecular Weight | 480.524 | nRot | 7 |
| Heavy Atom Molecular Weight | 456.332 | nRig | 31 |
| Exact Molecular Weight | 480.18 | nRing | 6 |
| Solubility: LogS | -5.845 | nHRing | 4 |
| Solubility: LogP | 3.971 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 6 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 4 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 4 | No. of Arom Atom | 26 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 30 |
| nHA | 6 | APOL | 70.371 |
| nHD | 3 | BPOL | 31.837 |
| QED | 0.283 |
| Synth | 3.472 |
| Natural Product Likeliness | 0.385 |
| NR-PPAR-gamma | 0.85 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.32 |
| Pgp-sub | 0.005 |
| HIA | 0.166 |
| CACO-2 | -5.141 |
| MDCK | 0.00000729 |
| BBB | 0.08 |
| PPB | 0.934849 |
| VDSS | 0.43 |
| FU | 0.0769615 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.976 |
| CYP2c19-inh | 0.932 |
| CYP2c19-sub | 0.171 |
| CYP2c9-inh | 0.949 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.774 |
| CYP2d6-sub | 0.9 |
| CYP3a4-inh | 0.82 |
| CYP3a4-sub | 0.765 |
| CL | 4.445 |
| T12 | 0.387 |
| hERG | 0.329 |
| Ames | 0.662 |
| ROA | 0.977 |
| SkinSen | 0.471 |
| Carcinogencity | 0.449 |
| EI | 0.025 |
| Respiratory | 0.99 |
| NR-Aromatase | 0.927 |
| Antiviral | Yes |
| Prediction | 0.622505 |